These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 39079155)

  • 41. [Pollinosis: drug treatments].
    Harf R
    Rev Mal Respir; 2013 Jun; 30(6):458-62. PubMed ID: 23835318
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Olopatadine: a drug for allergic conjunctivitis targeting the mast cell.
    Leonardi A; Quintieri L
    Expert Opin Pharmacother; 2010 Apr; 11(6):969-81. PubMed ID: 20307221
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Allergic rhinoconjunctivitis and immunotherapy: an update].
    Leimgruber A; Spertini F
    Rev Med Suisse; 2009 Jan; 5(186):88-93. PubMed ID: 19238924
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Allergic inflammation of the anterior surface of the eye.
    Bielory L
    Allergy Asthma Proc; 2020 Nov; 41(6):449-453. PubMed ID: 33109311
    [No Abstract]   [Full Text] [Related]  

  • 45. The allergic eye: recommendations about pharmacotherapy and recent therapeutic agents.
    Kimchi N; Bielory L
    Curr Opin Allergy Clin Immunol; 2020 Aug; 20(4):414-420. PubMed ID: 32558665
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical trials in allergic conjunctivits: a systematic review.
    Mantelli F; Lambiase A; Bonini S; Bonini S
    Allergy; 2011 Jul; 66(7):919-24. PubMed ID: 21261658
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A review of olopatadine for the treatment of ocular allergy.
    Abelson MB
    Expert Opin Pharmacother; 2004 Sep; 5(9):1979-94. PubMed ID: 15330735
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluating the efficacy of epinastine ophthalmic solution using a conjunctivitis allergen challenge model in patients with birch pollen allergic conjunctivitis.
    Tagawa Y; Namba K; Nakazono Y; Iwata D; Ishida S
    Allergol Int; 2017 Apr; 66(2):338-343. PubMed ID: 27720602
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Emerging drugs for ocular allergy.
    Leonardi A
    Expert Opin Emerg Drugs; 2005 Aug; 10(3):505-20. PubMed ID: 16083326
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The current and future therapy of allergic conjunctivitis.
    Friedlaender MH
    Curr Opin Ophthalmol; 1998 Aug; 9(4):54-8. PubMed ID: 10387470
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Trends in prevalence and treatment of ocular allergy.
    Gomes PJ
    Curr Opin Allergy Clin Immunol; 2014 Oct; 14(5):451-6. PubMed ID: 25115683
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Olopatadine (AL-4943A): ligand binding and functional studies on a novel, long acting H1-selective histamine antagonist and anti-allergic agent for use in allergic conjunctivitis.
    Sharif NA; Xu SX; Yanni JM
    J Ocul Pharmacol Ther; 1996; 12(4):401-7. PubMed ID: 8951676
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antihistamines in ocular allergy: are they all created equal?
    Abelson MB; McLaughlin JT; Gomes PJ
    Curr Allergy Asthma Rep; 2011 Jun; 11(3):205-11. PubMed ID: 21437647
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Olopatadine hydrochloride ophthalmic solution for the treatment of allergic conjunctivitis.
    Gonzalez-Estrada A; Reddy K; Dimov V; Eidelman F
    Expert Opin Pharmacother; 2017 Aug; 18(11):1137-1143. PubMed ID: 28656804
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [New aspects in drug therapy of ocular allergies].
    Maĭchuk IuF
    Vestn Oftalmol; 2000; 116(5):10-4. PubMed ID: 11221368
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Second generation antihistamines: an update.
    Sánchez-Borges M; Ansotegui IJ
    Curr Opin Allergy Clin Immunol; 2019 Aug; 19(4):358-364. PubMed ID: 31169593
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Management of seasonal allergic conjunctivitis: guide to therapy.
    Bielory BP; O'Brien TP; Bielory L
    Acta Ophthalmol; 2012 Aug; 90(5):399-407. PubMed ID: 22067457
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Doxycycline exerts multiple anti-allergy effects to attenuate murine allergic conjunctivitis and systemic anaphylaxis.
    Su W; Wan Q; Han L; Huang J; Chen X; Chen G; Zheng SG; Liang D
    Biochem Pharmacol; 2014 Oct; 91(3):359-68. PubMed ID: 25128381
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antihistamine use in children.
    Fitzsimons R; van der Poel LA; Thornhill W; du Toit G; Shah N; Brough HA
    Arch Dis Child Educ Pract Ed; 2015 Jun; 100(3):122-31. PubMed ID: 25147323
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Time to onset and duration of action of the antihistamine bepotastine besilate ophthalmic solutions 1.0% and 1.5% in allergic conjunctivitis: a phase III, single-center, prospective, randomized, double-masked, placebo-controlled, conjunctival allergen challenge assessment in adults and children.
    Abelson MB; Torkildsen GL; Williams JI; Gow JA; Gomes PJ; McNamara TR;
    Clin Ther; 2009 Sep; 31(9):1908-21. PubMed ID: 19843481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.